Methyl-.beta.-orcinolcarboxylate from lichen (everniastrum cirrhatum) for use for the treatment of fungal infections and cancer
CA 2521055 A1 · Owner: Shasany, Ajit Kumar · Inventors: Verma, Subash Chandra; Chand, Preeti; Pal, Anirban
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to the new use of an already known biomolecule methyl-.beta.-orcinol carboxylate of formula (I) isolated from a lichen (Everniastrum cirrhatum), for treating pathogenic fungal infections of humans that are resistant to polyene and azole antibiotics such as amphotericin B nystatin, clotrimazole etc.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 31, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 31, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 31, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.